I. Introduction and assay characteristics
Short tandem repeat (STR) markers are increasingly used for monitoring the engraftment of donor cells after stem cell transplantation. [1] [2] [3] [4] [5] [6] [7] [8] In this setting, donor:recipient chimerism in highly purified leukocyte subsets seems to be more informative for detection of graft failure or relapse of the disease than quantification of chimerism in whole peripheral blood (PB) or bone marrow (BM). 1, 3, 4, [8] [9] [10] [11] Determination of donor chimerism should lead to comparable results in different laboratories, which implies that results ought to be independent of the STR primers and the detection system used. We compared a singleplex in-house STR primer set PCR 12 (Table 1) with two commercially available multiplex PCR systems (AmpFISTER Profiler, [5] [6] [7] 13, 14 AmpFISTER SGM Plus PCR amplification kit; 7, 15 Applied Biosystems/ABI/, Weiterstadt, Germany) in a patient with thalassemia. PCR products were assessed by both capillary electrophoresis (ABI Prism 310 genetic analyzer) and polyacrylamide gel electrophoresis (PAGE) systems (ABI Prism 373 DNA sequencer).
II. Protocols
Sample preparation procedure, PCR and detection method for our routinely used in-house PCR is described in detail. Median numbers of informative STRs were evaluated in samples of our pediatric patients (n = 23) with leukemia and thalassemia in PB, BM and leukocyte subsets at various time-points after transplantation. The two commercially available multiplex PCR systems are characterized briefly. Detailed descriptions of the AmpFISTER Profiler and the AmpFISTER SGM Plus PCR amplification kits are given by the manuals of the manufacturer and by Thiede et al. + stem cells was done by two-step immunomagnetic separation using two columns and the MiniMacs system according to the manufacturer's instructions (Miltenyi Biotec). Finally, CD34
+ cells were eluted with 500 l PBS/EDTA/HSA buffer. Next, the negative fraction was divided into three parts for the following selection step. The parts were incubated for 15 min at 4°C with ferrobead-conjugated antibodies against CD3, CD56 and CD14, respectively. For patients with B-ALL, CD19 antibodies were used instead of CD14. Subsequently, positive enrichment was performed as described for CD34 + cells. Depending on the number of labeled cells, the MiniMacs or the VarioMacs as well as the AutoMacs were used. The selections were performed in parallel. The purified CD3 + , CD14
+ and CD19 + cells were used directly for flow-cytometric assessment of purity and for DNA extraction. The negative fractions were concentrated for the next selection step. Cells were incubated with the respective antibodies for 15 min at 4°C. The CD3-depleted negative fraction was used for labeling with CD56 antibodies to select CD56 + CD3 − natural killer (NK) cells. The CD14-depleted negative fraction was processed by incubating with CD4 antibodies for subsequent selection of CD4 + CD3 + Thelper cells. The CD56-depleted negative fraction was labeled with CD8 antibody beads to purify CD8
− cytotoxic T cells. All bead-conjugated monoclonal antibodies were obtained from Miltenyi Biotec. The order of selection/depletion steps is essential to avoid contamination of (1) is especially important in the early period after transplantation, when hematopoietic recovery of the lymphocytes shows a huge NK cell plateau. The various enrichment steps led to a median purity of Ͼ90.5% for each leukocyte subset. Finally, DNA was extracted from 200 l PB, BM or from 10 000-120 000 cells of the purified leukocyte subsets using standard DNA extraction method (QiAamp DNA Mini Kit or Blood Mini Kit; Qiagen, Hilden, Germany) as recommended by the manufacturer. DNA was quantified using both standard UV-absorption at 260 nm in a DU 640-VIS Spectrophotometer (Beckman Coulter, Krefeld, Germany) and gel electrophoresis.
Flow-cytometric analysis
Four-color flow cytometric analysis was performed on a Coulter Epics XL (Beckman Coulter, Krefeld, Germany) to determine the percentage of the leukocyte subsets prior to and after selection. 1 × 10 4 -1 × 10 6 cells were labeled in separate tubes for 20 min with CD45-FITC/CD4-PE/CD8-ECD/CD3-PC5, CD45-FITC/CD56-PE/CD19-ECD/CD3-PC5 and CD45-FITC/CD14-PE (Coulter Immunotech, Marseille, France). IgG1-FITC/IgG1-PE/IgG1-ECD/IgG1-PC5 staining served as control. The Stem-Kit CD34 HPC enumeration kit (CD45FITC/CD34PE, stem-count beads; Coulter Immunotech) with additional 7-AAD staining to exclude dead cells was used to evaluate the purity and the absolute count of CD34 + cells according to the ISHAGE (International Society of Hematotherapy and Graft Engineering) protocol.
PCR (a) In-house STR primer system:
The 11 primer pairs of the in-house STR primer set were synthesized and labeled commercially with the fluorescence dye markers FAM, HEX or TAMRA (Applied Biosystems) as shown in Table 1 . PCR amplification was performed in a 9600 DNA thermal cycler system (Applied Biosystems) using 50 ng of genomic DNA for whole PB or BM and 2-10 ng DNA for purified leukocyte subsets, respectively. 25 pmol of each primer, 200 nmol dNTPs, 1 × PCR buffer and 0.5 U Taq polymerase (Appligene Oncor, Heidelberg, Germany) were added in a final volume of 50 l. The cycle conditions were: 95°C for 5 min, followed by 30 cycles with 95°C for 90 s, 54°C for 40 s, 72°C for 30 s, with a final extension step at 72°C for 5 min.
(b) Multiplex STR primer systems:
The commercially available AmpFISTER Profiler PCR amplification kit contains all the reagents necessary to amplify the D3S1358, vWA, FGA, THO1, TPOX, CSF1PO, D5S818, D13S317 and D7S820 loci in sample DNA, ready to follow the instructions of the manufacturer. The STR primers contained in AmpFISTER SGM Plus PCR Kit are: DS31358, vWA, FGA, D8S1179, D21S11, D18S51, D5S818, D13S317 and D7S820. Additionally, with both multiplex PCR kits the Amelogenin locus was analyzed which discriminates the X and Y chromosomes. PCR conditions for both multiplex PCR amplifications in an ABI 9600 DNA thermal cycler were as follows: 95°C for 11 min, followed by 28 cycles with 94°C for 1 min, 59°C for 1 min and 72°C for 1 min and a final elongation step of 45 min at 60°C according to the manufacturer's instructions.
Gel electrophoresis (a) PAGE:
The in-house PCR products were analyzed using an allelic ladder on a 6% polyacrylamide denaturing sequencing gel containing 8.3 M urea and 6% acrylamide/bissolution buffer. Depending on the concentration of the PCR products, the PCR reactions were diluted up to 1:40 with deionized water. Subsequently, between four and seven different informative PCR reactions were mixed for one gel electrophoresis. After adding 3 l of the mixed PCR products to 3 l loading buffer, 5 l were loaded on the gel. Electrophoresis was performed at 30 W for 8 h on an automated ABI Prism 373 DNA sequencer.
(b) Capillary electrophoresis:
The in-house and the multiplex PCR fragments were detected with an ABI Prism 310 Genetic Analyzer. First, 1-2 l of the PCR reactions were mixed with 18 l HIDI formamide (Applied Biosystems). Then, the samples were denaturated at 90°C for 2 min and subsequently chilled in an ice-water bath. For capillary electrophoresis the POP-4 polymer with the short 47 cm capillary was used.
Quantification of donor chimerism
Fragments were analyzed using the Genescan 2.1 and 3.1 software (Applied Biosystems). The software allows for an easy determination and labeling of the informative STRs of the pretransplant donor and recipient samples. The results can be compared directly to the post-transplant samples as described in detail by Thiede et al. 6 The donor percentage peak area was calculated as shown by Sharf et al: 16 % Donor: (Donor + Recipient) = (A D1 + A D2 ) × 100/(A D1 + A D2 + A R1 + A R2 ), where A is peak area, D donor allele(s), and R recipient allele(s).
If an allele is shared, only the alleles that distinguish donor from recipient were used for calculation.
Time requirement
Fluorescence-based quantitation of chimerism by capillary electrophoresis or PAGE allows for an automated large-scale processing of post-transplant samples. Starting from PB or BM samples, final results can be obtained by single as well as multiplex PCR both in unseparated leukocytes within 1 day and in highly purified subsets until next day, which facilitates therapeutic decisions.
Statistical analysis
The matching probability was calculated by the method of Jones. 17 The expected frequency of heterozygotes was calculated according to Nei and Roychoudhury. 18 Mann-Whitney U-test and Dixon-test were used for statistical analysis.
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III. Informativeness and characteristics of the in-house PCR
Calculation of donor chimerism in the 23 patients investigated was based on a median number of six (range 3-9) informative STR loci per patient. The median number of informative STRs per patient was five (range 3-5) for matched related donors (n = 6), seven (range 4-9) for matched unrelated donors (n = 10) and seven (range 3-9) for two and three mismatch haploidentical donors (n = 7). Calculation of the individual chimerism results based on between three and nine informative STRs per patient led to a standard deviation of Ͻ4.2% in PB (n = 297), <5.5% in BM (n = 46) and Ͻ6.9% (n = 39) in the purified leukocyte subsets CD3
+ , CD34 + and CD19 + . Table 1 summarizes the characteristics of our in-house primer system and the informativeness of the STRs evaluated.
IV. Comparison: in-house vs multiplex-PCR and PAGE vs capillary electrophoresis
In one patient with thalassemia, donor chimerism was assessed in two PB samples (42 and 46 weeks after transplantation) and enriched CD3 + cells (purity 97.7%) by singleplex in comparison to multiplex PCR and capillary electrophoresis vs PAGE. Donor chimerism could be detected with five informative in-house STR loci (No. 1-5, Table 1 ). The patient showed stable mixed chimerism in whole PB and BM and within purified leukocyte subsets during the followup period of 14 months. In this patient, two informative STR loci were found with the commercially available AmpFISTER Profiler kit (TH01, D5S818) and three informative STR loci with the AmpFISTER SGM Plus kit (D8S1197, D18S51, D5S818). The STR loci THO1 and D18S51 were also part of the in-house singleplex PCR system. Our results, summarized in Table 2 , demonstrate that comparable quantitative values were obtained for the donor chimerism using the singleplex in-house STR test and the multiplex STR approach. Furthermore, only marginal differences were found between PAGE and capillary electrophoresis. For PB and CD3-selected cells the results did not differ significantly. Similarly, determination of chimerism in the second PB sample obtained 46 weeks after transplantation revealed only minor differences between the different PCR and detection systems (data not shown). Our preliminary data indicate that molecular assessment of chimerism using STR markers may be performed with a wide variety of STR loci either by single or multiplex PCR. Given the low number of experiments, no further conclusions can be drawn. Additional studies are therefore needed.
In conclusion, our experience suggests that analysis of molecular chimerism by STR loci gives reproducible results. Therefore, inter-laboratory standardization for quantitative assessment of mixed chimerism seems possible. However, chimerism testing using STR loci 1, 5, 6, 8, 13 remains to be evaluated in comparison to variable tandem repeats as used in other laboratories 2,3,9 Inter-laboratory standardization of different methods should be established [21] [22] [23] [24] [25] [26] to permit quick Leukemia therapeutic interventions on the basis of increasing mixed chimerism.
